<a href="https://laohu8.com/S/RGNX">Regenxbio Inc</a>. Conducted Annual Stockholders Meeting
Regenxbio Inc. held its Annual Meeting of Stockholders on May 30, 2025. During the meeting, several proposals were considered. Allan Fox, Alexandra Glucksmann, Ph.D., Curran Simpson, and Jennifer Zachary were elected as Class I directors. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the year ending December 31, 2025, was ratified. The stockholders voted to hold future advisory votes on executive compensation every year. Additionally, the Regenxbio Inc. 2025 Equity Incentive Plan was approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenxbio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-080986), on June 03, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。